Find clinical trials for Acute Myeloid Leukemia (AML) in St Louis, MO
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near St Louis, MO, USA:
allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...
Phase 3
Saint Louis, Missouri, United States and 23 other locations
the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary anti-leukemic activity of WU-NK-101 in R/R AML....
Phase 1
Saint Louis, Missouri, United States and 8 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Saint Louis, Missouri, United States and 82 other locations
This study will be conducted in two parts. Part 1 will be the Dose Confirmation portion to determine recommended Phase 3 dose (RPTD) of venetoclax in...
Phase 3
Saint Louis, Missouri, United States and 160 other locations
to placebo and VEN+AZA alone for the treatment of participants with Acute Myeloid Leukemia (AML) with a mutation ...
Phase 3
St Louis, Missouri, United States and 140 other locations
and Venetoclax in participants with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndro...
Phase 1
Saint Louis, Missouri, United States and 14 other locations
). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy....
Phase 2
St Louis, Missouri, United States and 32 other locations
GDX012 is a novel cell therapy developed for the treatment of certain types of cancer, including Acute Myeloid Leukemia (A...
Phase 1, Phase 2
St Louis, Missouri, United States and 13 other locations
with cytarabine in patients with relapsed/refractory (r/r) acute myeloid leukemia (AML) or r/r higher-risk myelod...
Phase 1
St. Louis, Missouri, United States and 9 other locations
This first-in-human study will evaluate RVU120 (SEL120), a novel small molecule CDK8/19 inhibitor, in patients with Acute Myeloid L...
Phase 1
Saint Louis, Missouri, United States and 9 other locations
Clinical trials
Research sites
Resources
Legal